FTC Final Order finds ProMedica’s acquisition of St. Luke’s Hospital presumptively illegal; orders divestiture
The Federal Trade Commission has found that ProMedica’s acquisition of St. Luke’s Hospital is anticompetitive. The FTC has thus voted 4-0 to order ProMedica to divest St. Luke’s Hospital within six months after the order is effective.
The FTC found that the acquisition was likely to lead to diminished competition and increased prices for the two Toledo, Ohio service markets of general acute-care inpatient hospital services and inpatient obstetric services sold to commercial health plans. Although the FTC’s market definition differed from the one employed by the ALJ in December 2011, Commissioner Julie Brill noted that “market shares and concentration levels exceed the thresholds for presumptive illegality provided in the 2010 Horizontal Merger Guidelines and the case law.” The merged hospital’s increase in market power would ultimately result in higher health care costs for all involved: patients, employers, and employees.
Full content: FTC Press Release
Related content: WARNING: Improper Use of the New Horizontal Merger Guidelines Can Result in Overly Narrow Markets, Mistaken Inferences of Market Power, and Wrong-Headed Analyses (Michael Doane, Competition Economics LLC; Luke Froeb, Vanderbilt Owen Graduate School of Management; Steven Tschantz, Vanderbilt University)
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas